摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,6-dihydro-[1,2]oxathiine 2,2-dioxide | 5809-61-0

中文名称
——
中文别名
——
英文名称
3,6-dihydro-[1,2]oxathiine 2,2-dioxide
英文别名
3,6-Dihydro-2H-1,2lambda~6~-oxathiine-2,2-dione;3,6-dihydrooxathiine 2,2-dioxide
3,6-dihydro-[1,2]oxathiine 2,2-dioxide化学式
CAS
5809-61-0
化学式
C4H6O3S
mdl
——
分子量
134.156
InChiKey
GACHDGIRDQPROE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    51.8
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,6-dihydro-[1,2]oxathiine 2,2-dioxide对苯二酚三氯氧磷 作用下, 反应 45.0h, 生成 (Z)-buta-1,3-diene-1-sulfonyl chloride
    参考文献:
    名称:
    Stereospecific synthesis of 1Z,3E-butadiene-1-sulfonic acids from ?,?-unsaturated ?-sultones and ?-sultams
    摘要:
    DOI:
    10.1007/bf00960273
  • 作为产物:
    描述:
    allyl prop-2-enesulfonateRuCl2(1,3-dimesityl-imidazolidin-2-yl)(PCy3)(=CHPh) 作用下, 以 二氯甲烷 为溶剂, 反应 0.12h, 以82%的产率得到3,6-dihydro-[1,2]oxathiine 2,2-dioxide
    参考文献:
    名称:
    闭环复分解合成磺内酯
    摘要:
    通过磺酸盐的闭环复分解有效地合成了具有正常、中等和大环尺寸的不饱和磺内酯。所需的底物很容易从烯醇和烯属磺酰氯衍生而来。
    DOI:
    10.1055/s-2002-35560
点击查看最新优质反应信息

文献信息

  • Ring Closing Metathesis in the Synthesis of Sultones and Sultams
    作者:Peter Metz、Sandra Karsch、Dirk Freitag、Pia Schwab
    DOI:10.1055/s-2004-822408
    日期:——
    synthesized by ring closing metathesis (RCM) of sulfonates. The resulting α,β-unsaturated sultones act as dienophiles in intermolecular Diels-Alder reactions. A first cyclic sulfate formation through RCM has been discovered, and a rapid access to p-lactams fused to a sultam moiety of variable ring size was developed from inexpensive, commercially available starting materials using RCM as the key operation
    通过磺酸盐的闭环复分解(RCM)有效地合成了具有正常、中等和大环尺寸的不饱和磺内酯。所得的 α,β-不饱和磺内酯在分子间 Diels-Alder 反应中充当亲双烯体。已经发现了通过 RCM 形成的第一个环状硫酸盐,并且使用 RCM 作为关键操作,从廉价的、可商购的起始材料开发了一种快速获得稠合到可变环大小的磺胺部分的 p-内酰胺的方法。还描述了一种有效的 4-vinyl-azetidin-2-ones 生成 1-aza-bicyclo[4.2.0]oct-4-en-8-ones 的 RCM。
  • Flohic, Alexandre Le; Meyer, Christophe; Cossy, Janine, Synlett, 2003, # 5, p. 667 - 670
    作者:Flohic, Alexandre Le、Meyer, Christophe、Cossy, Janine、Desmurs, Jean-Roger、Galland, Jean-Christophe
    DOI:——
    日期:——
  • Reactivity of unsaturated sultones synthesized from unsaturated alcohols by ring-closing metathesis. Application to the racemic synthesis of the originally proposed structure of mycothiazole
    作者:Alexandre Le Flohic、Christophe Meyer、Janine Cossy
    DOI:10.1016/j.tet.2006.07.010
    日期:2006.9
    Unsaturated sultones have been synthesized from various primary or secondary alkenols by ring-closing metathesis of the corresponding unsaturated sulfonates. By treatment with a strong base, beta,gamma-unsaturated sultones can be metalated and subsequently alkylated with electrophiles. When iodomethylmagnesium chloride was selected as the electrophile, seven-membered ring beta,gamma-unsaturated sultones were converted into homoallylic conjugated (Z)-dienols. This methodology was applied to the racemic synthesis of the originally proposed structure of the marine natural product mycothiazole. (c) 2006 Elsevier Ltd. All rights reserved.
  • Synthesis and properties of sulfoalkenyl amides
    作者:I. M. Zaks、B. S. �l'ynov、V. M. Zhulin、A. M. Moiseenkov
    DOI:10.1007/bf01141714
    日期:1984.5
  • SEMENOVSKIJ A. V.; POLUNIN E. V.; ZAKS N. M.; MOISEENKOV A. M., IZV. AN CCCP. CEP. XIM., 1979, HO 6, 1327-13331
    作者:SEMENOVSKIJ A. V.、 POLUNIN E. V.、 ZAKS N. M.、 MOISEENKOV A. M.
    DOI:——
    日期:——
查看更多

同类化合物

6-乙氧基-2-甲基-5,6-二氢-1,4-氧硫杂环己二烯-3-羧酸 5,6-二氢-1,4-氧硫杂环己二烯-2-羧酸 5,6,7,8-四氢-4,7-二甲基-1,2-苯并氧硫杂环己二烯 2,2-二氧化物 2-甲基-5,6-二氢-1,4-氧硫杂环己二烯-3-甲酸 2-甲基-1,4-氧硫杂环己二烯-3-羧酸 1-(6-乙氧基-2-甲基-4-氧代-5,6-二氢-1,4-氧硫杂环己二烯-3-基)乙酮 1,4-苯并氧硫杂环己二烯4,4-二氧化物 1,4-氧硫杂环己二烯 1,4-噁噻英,2,3-二氢-5,6-二甲基- 1,2-苯并噁噻英,3,4-二氢- 1,2-氧硫杂环己二烯 5,6-dihydro-[1,4]oxathiine-2,3-dicarboxylic acid dimethyl ester (6-[1,3]Dithian-2-ylmethyl-benzo[1,3]dioxol-5-yl)-carbamic acid tert-butyl ester 2,6-dimethyl-4-(1,1,3,3-tetraoxo-1λ6,3λ6-[1,3]dithietan-2-ylidene)-4H-pyran Pyrrolidine,1-(3-chloro-3,4,5,6,7,8-hexahydro-2,2-dioxido-1,2-benzoxathiin-4-yl)-,trans- β-Methyl-β-dimethylamino-pent-3-en-sulfonsaeure-sulton (2,2-Dioxo-6-phenyl-3,4-dihydro-2H-2λ6-[1,2]oxathiin-4-yl)-diethyl-amine 6,12,18,24,25,27,29,31-octachloro-2,8,14,20-tetraoxa-3λ6,9λ6,15λ6,21λ6-tetrathiapentacyclo[20.2.2.24,7.210,13.216,19]dotriaconta-1(25),4(32),5,7(31),10(30),11,13(29),16(28),17,19(27),22(26),23-dodecaene 3,3,9,9,15,15,21,21-octaoxide O-methyl-(5,6-dihydro-2-methyl-1,4-oxathiin-3-yl)carbonyl carbamothioate 6-tert-Butyl-N,N,2-trimethyl-4-oxo-4H-3,1-benzoxathiin-8-carboxamid-1-oxid Dimethyl-(4-methyl-2,2-dioxo-3,6-dihydro-2H-2λ6-[1,2]oxathiin-5-yl)-amine (2S,6S)-2,6-Diethyl-4-ethylsulfanyl-5-methyl-6H-[1,3]oxathiine 5,6-dihydro-2-methyl-1,4-oxathiin-3-carboxylic acid hydrazide 18-methoxy-5,8,11-trioxa-2,14-dithia-18-azabicyclo[13.2.1]octadeca-1(17),15-diene 9',10'-dihydrospiro[cyclohexane-1,11'-[9,10](epithiooxymethano)anthracene] 13',13'-dioxide 6-(Morpholin-4-methyl)-2-(4-morpholinyl)-1,4,3-oxathiazin-4,4-dioxid 3-Methoxy-1,8,8-trioxo-2-oxa-8λ6-thia-spiro[4.5]deca-6,9-diene-3-carboxylic acid methyl ester 41,42-dimethoxy-5,8,11,14,25,28,31,34-octaoxa-2,17,22,37-tetrathia-41,42-diazatricyclo[36.2.1.118,21]dotetraconta-1(40),18,20,38-tetraene 35,36-dimethoxy-5,8,11,22,25,28-hexaoxa-2,14,19,31-tetrathia-35,36-diazatricyclo[30.2.1.115,18]hexatriaconta-1(34),15,17,32-tetraene 2,2-dimethyl-4-phenyl-6,6-bis-trifluoromethyl-6H-[1,3,5]oxathiazine 3-(1,1,2,2,3,3-hexafluoropropyl)-4-thia-2-hexen-6-olide 21-methoxy-5,8,11,14-tetraoxa-2,17-dithia-21-azabicyclo[16.2.1]henicosa-1(20),18-diene 3-bromo-4,6-diphenyl-[1,2]-oxathiine 2,2-dioxide (Z)-7,8-Dihydro-4H-1,3-oxathiocin-2-one (E)-4-Methyl-7,8,9,10-tetrahydro-4H-[1,3]oxathiecin-2-one 1-(2,2-Dioxo-3,4,7,8-tetrahydro-2H,5H-2λ6-thiopyrano[3,4-e][1,2]oxathiin-4-yl)-piperidine 1-(2,2-Dioxo-3,4,5,6-tetrahydro-2H-2λ6-thieno[3',2':3,4]benzo[1,2-e][1,2]oxathiin-4-yl)-piperidine 24-methoxy-5,8,11,14,17-pentaoxa-2,20-dithia-24-azabicyclo[19.2.1]tetracosa-1(23),21-diene 47,48-dimethoxy-5,8,11,14,17,28,31,34,37,40-decaoxa-2,20,25,43-tetrathia-47,48-diazatricyclo[42.2.1.121,24]octatetraconta-1(46),21,23,44-tetraene 5-Isopropyl-2,3-dihydro-[1,4]oxathiine 1-(2,2-Dioxo-3,4,5,6-tetrahydro-2H-2λ6-thieno[3',2':3,4]benzo[1,2-e][1,2]oxathiin-4-yl)-pyrrolidine (5,6-dihydro-1,4-oxathiin-3-yl)acetic acid 2-(2-Methyl-allyl)-1-(2-methyl-5,6-dihydro-[1,4]oxathiine-3-carbonyl)-isothiourea 6-ethoxy-5,6-dihydro-2-methyl-1,4-oxathiin-3-carbonyl chloride 6-Cyclopropyl-2,3-dihydro-1,4-oxathiine-5-carboxylic acid 2-Methyl-6-(trifluoromethyl)-2,3-dihydro-1,4-oxathiine-5-carboxylic acid 3-Methyl-6-(trifluoromethyl)-2,3-dihydro-1,4-oxathiine-5-carboxylic acid 3,4,6-trimethyl-[1,2]oxathiin-2,2-dioxide 2-Methyl-4-heptyl-butadien-(1.3)-sulton-(1.4)